ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

National Academy of Sciences awards Kovalenko medal to immunotherapy pioneer Allison – EurekAlert (press release)

EurekAlert (press release)National Academy of Sciences awards Kovalenko medal to immunotherapy pioneer AllisonEurekAlert (press release)HOUSTON – Cancer immunotherapy innovator Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Ander… Continue reading

2018-01-17 Michael Zand NEWS

Cancer Immunotherapy Channeled via Remote Control – Genetic Engineering & Biotechnology News

Continue reading

2018-01-17 Michael Zand NEWS

The hottest thing in cancer drug development is a takeover target again — here’s what you need to know about it – Business Insider


Reader’s Digest

Cancer Immunotherapy Channeled via Remote Control
Genetic Engineering & Biotechnology News
We’re a long way from controlling our immune systems as easily as we might change the channels on our televisions, but a new remote-control system, in the hands of clinicians, could enable the narrowcasting of immunotherapies. For example, cancer …
Researchers develop a remote-controlled cancer immunotherapy systemDrug Target Review
Minimally Invasive Cancer Therapies to Gain PrevalenceEdition Truth

all 7 news articles »

Continue reading

2018-01-17 Michael Zand NEWS

How scientists are mapping the building blocks of life – Massive


Business Insider

The hottest thing in cancer drug development is a takeover target again — here’s what you need to know about it
Business Insider
Instead of getting a better, updated therapy for a disease every decade or so, we might begin to see second-generation cell therapies in a few years. One challenge these therapies still face is how toxic they can be. CAR–T’s side effects can be deadly …
CAR T-Cell Therapy Gets Priority Review for Lymphoma TreatmentCuretoday.com
FDA Grants Priority Review to CAR T-Cell Therapy Tisagenlecleucel for DLBCLwww.oncnursingnews.com/
Speedy EU, US review for Novartis’ CAR–T therapy KymriahPharmaTimes
Canada NewsWire (press release) –The FINANCIAL –WHTC
all 14 news articles »
Continue reading

2018-01-17 Michael Zand NEWS

6 amazing medical advancements to expect in 2018 – CNBC


Massive

How scientists are mapping the building blocks of life
Massive
This is not biology’s first attempt at an ambitious, “man-on-the-moon” project, and past initiatives have proven tremendously beneficial to science. The impact of the Human Genome Project (HGP) cannot be understated, for example: it has accelerated the …

Continue reading

2018-01-17 Michael Zand NEWS

At $850000, price for new childhood blindness gene therapy four times too high, analysis says – Pharmacy Today, American Pharmacists Association, pharmacist.com


Genetic Literacy Project

6 amazing medical advancements to expect in 2018
CNBC
“If you look at cancer, we know the majority of cancer starts with a DNA defect,” Dr. Roizen says. “And that DNA defect can be corrected or ameliorated. Say you have a family who has in vitro fertilization; they will examine the genes of the embryo …
Report: Price for blindness gene therapy Luxturna is ‘four times too high’ at $850000Genetic Literacy Project

all 4 news articles »

Continue reading

2018-01-17 Michael Zand NEWS

First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy – PR Newswire (press release)

First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene TherapyPR Newswire (press release)HACKENSACK, N.J., Jan. 17, 2018 /PRNewswire-USNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the… Continue reading

2018-01-17 Michael Zand NEWS

Report: Price for blindness gene therapy Luxturna is ‘four times too high’ at $850000 – Genetic Literacy Project


Genetic Literacy Project

At $850000, price for new childhood blindness gene therapy four times too high, analysis says
Pharmacy Today, American Pharmacists Association, pharmacist.com
voretigene neparvovec-rzyl (Luxturna—Spark Therapeutics), the first-of-its-kind gene therapy for a form of childhood blindness caused by a mutation in the RPE65 gene, is approximately four times too high for the value the drug provides. In a new …
Report: Price for blindness gene therapy Luxturna is ‘four times too high’ at $850000Genetic Literacy Project
6 big medical advancements to expect in 2018CNBC

all 3 news articles »

Continue reading

2018-01-17 Michael Zand NEWS
  • 1
  • …
  • 652
  • 653
  • 654
  • 655
  • 656
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Genetic Literacy Project

Report: Price for blindness gene therapy Luxturna is ‘four times too high’ at $850000
Genetic Literacy Project
The report from the Institute for Clinical and Economic Review focused on the medicine Luxturna, the first-of-its-kind gene therapy approved for the U.S. market and the most expensive medicine by list price. It is the latest flashpoint in the debate …
At $850000, price for new childhood blindness gene therapy four times too high, analysis saysPharmacy Today, American Pharmacists Association, pharmacist.com
6 amazing medical advancements to expect in 2018CNBC
Spark Therapeutics: Challenges Posed By SuccessSeeking Alpha

all 4 news articles »